Tuesday, December 23, 2025
8.4 C
London

Tag: Botanix Pharmaceuticals

Botanix Pharmaceuticals: Passes FDA mid-cycle review for Sofpironium Bromide

Botanix Pharmaceuticals Passes FDA mid-cycle review for Sofpironium Bromide Botanix Pharmaceuticals’ (BOT) lead product, Sofpironium Bromide, passes an FDA...

Botanix Pharmaceuticals: Ends Q1 FY21 financially strong

Botanix Pharmaceuticals has released its September quarterly report, showing the company ended the period with a strong $22.1M...